hexenoyl cap raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-26 and is reviewed periodically as new material appears.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Amino acid length | 44 residues | Matches the native peptide backbone |
| Molecular weight | Approximately 5135 Da | Calculated from the peptide sequence |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
| Primary studied use | Visceral fat reduction | Investigated in HIV-associated lipodystrophy |
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
Carbon nanotubes with amine groups provide numerous chemical sites for carbon dioxide adsorption at low temperature ranges of 20°-100° degrees Celsius. Van der Waals forces and π-π interactions also are used to pull molecules onto surface functional groups. Fullerene can be used to rid of carbon dioxide pollution due to its high adsorption capacity. Graphene nanotubes have functional groups that adsorb gases. There are plenty of nanocatalysts that can be used for air pollution reduction and air quality. Some of these materials include 〖TiO〗_2, Vanadium, Platinum, Palladium, Rhodium, and Silver. Catalytic industrial emission reduction, car exhaust reduction, and air purification are just some of the major thrusts that these nanomaterials are being utilized within. Certain applications are not widely spread, but other are more popular. Indoor air pollution is barely on the market yet, but it is being developed more efficiently due to complications with health effects. Car exhaust emission reduction is widely used in diesel fueled automobiles currently being one of the more popular applications. Industrial emission reduction is also widely used. It is n integral method specifically at coal fired power plants as well as refineries. These methods are analyzed and reviewed using SEM imaging to ensure its usefulness and accuracy. Additionally, research is currently being conducted to find out if nanoparticles can be engineered to separate car exhaust from methane or carbon dioxide, which has been known to damage the Earth's ozone layer.
British Post Office scandal: Court documents reveal that Fujitsu, the company at the centre of the Post Office scandal, won a £184m contract by the Foreign and Commonwealth Office in 2021, despite concerns the system it was offering was "unfit for purpose". Court documents show that former prime minister Sir Tony Blair was warned the Horizon IT system could be "possibly unreliable" before it was rolled out, and raised concerns about it, but gave it the green light after receiving reassurance from others, including his Secretary of State for Trade and Industry Peter Mandelson. 13 January – Yvonne Tracey, a former deputy postmistress from New Malden, south London, announces her intention to stand in the Parliamentary constituency of Kingston and Surbiton, Sir Ed Davey's seat, at the next general election. 14 January – Foreign Secretary David Cameron tells the BBC that military action was taken against Houthi rebels because the strikes were needed after months of attacks against cargo ships, and that the UK is "prepared to back our words with actions". 15 January – Sunak tells Parliament that air strikes against Houthi targets were meant as a "limited, single action" but that the UK "will not hesitate to protect our security, our people and our interests where required". James Stockan announces he is stepping down from the post of leader of Orkney Islands Council, as well as relinquishing his council seat, after six years in the role.
If Carcass wasn't killed and Simon didn't give the gun to the doctor, he kills Sophie, his therapist, and then himself. He leaves a suicide note stating that he would have killed more people if it weren't for his disability and wishes that the people who find his body are haunted by it for the rest of their life. If Carcass wasn't killed and Simon gave the gun to the doctor, he kills Sophie, then himself. In his suicide note, he apologizes to his therapist and thanks him for his help, explaining that he killed Sophie so that he could have her all to himself since he never got over her rejection. If Carcass was killed and Simon didn't give the gun to the doctor, he kills his doctor, then himself. In his suicide note, he states that the doctor's therapy only made things worse, and begs for Sophie not to know what he's done. If Carcass was killed and Simon gave the gun to the doctor, Simon, right before he kills himself, is confronted by Book Simon. The player, taking control of the real Simon, chases down and kills Book Simon in a shootout. Coming to his senses, Simon realizes he had a mental episode. Instead of taking his own life, he killed two police officers who were presumably checking in on him. Simon gets admitted into a mental hospital for the rest of his life, where his therapist continues to look after him. Sophie, despite how much Simon hurt her, visits him. Hopeful about the future and finally at peace with his demons, Simon finishes his book.
Sources: en.wikipedia.org
== Extraction == β-glucan extraction from oat can be difficult due to tendency of depolymerization – which often occurs in high pH. Thus β-glucan extraction is usually performed under a more neutral pH and generally at temperatures of 60–100 °C (140–212 °F). Usually β-glucan is solubilized in the extraction process with residual starch, which is then removed by hydrolysis with alpha-amylase. The residual solution usually contains coextracts of hemicelluloses and proteins which can then be separated through selective precipitation. Through wet milling, sieving, and solvent-extraction, oat beta-glucans can achieve up to 95% extraction purity.
== History == Prime Minister, Narendra Modi had envisioned roll-out of a technology based citizen facing platform for smooth running of COVID-19 vaccination in India, long back in May 2020. The government repurposed its eVIN platform and tested it in more than 700 districts before the launch of CoWIN. However, the PM sensed that the technological backbone would need more robustness and decided to revive the team that had delivered Aadhaar and brought Dr RS Sharma on board who previously headed the Telecom Regulatory Authority of India and the Unique Identification Authority of India. Within days, Sharma was appointed Chair of the Empowered Group of technology and Data management and member of National Expert Group on Vaccine Administration(NEGVAC), a body constituted by the Government of India and also the CEO of the National Health Authority (NHA). CoWIN software was designed by Trigyn Technologies and KPMG India was hosted on Amazon Web Services. On 16 January 2021, CoWIN was launched and started offering COVID-19 vaccination for Frontline Workers in the country. On 1 March 2021, the platform started offering vaccination to all residents over the age of 60, residents between the ages of 45 and 60 with one or more qualifying comorbidities, and any health care or frontline worker that did not receive a dose during phase 1. From 1 April 2021, eligibility was extended to all residents over the age of 45. Registration for the next phase began on 28 April 2021 for 1 May 2021, extending eligibility to all residents over the age of 18.
Tofu was introduced to Japan by Zen Buddhist monks, who initially called it "Chinese curd" (唐符, tōfu). The earliest Japanese document concerning tofu refers to the dish being served as an offering at the Kasuga Shrine in Nara in 1183. The tofu that was introduced from China is thought to have originally been hard tofu such as island tofu from Okinawa, hard tofu from Hakusan City in Ishikawa Prefecture, Gokayama City in Toyama Prefecture, and Iya region in Tokushima Prefecture. Gradually, production methods were devised to produce smooth tofu with a pleasant texture, and modern silken tofu was born. The book Tofu Hyakuchin (豆腐百珍), published in 1782 of the Edo period, lists 100 recipes for cooking tofu.
Sources: en.wikipedia.org
=== Growth hormone receptor mutations === Molecular genetic investigations have shown that LS is mainly associated with autosomal recessive mutations in the gene for the growth hormone receptor (GHR). These can result in defective hormone binding to the ectodomain or reduced efficiency of dimerization of the receptor after hormone occupancy. LS is generally classified as "primary" GH insensitivity, which is distinguished from "secondary" GH insensitivity. Primary (congenital/hereditary) GH insensitivity may result from growth hormone receptor defects, as in the case of Laron syndrome, but can also be caused by defective post-receptor signal transduction (STAT5B), abnormalities of the IGF-1 gene or IGF-1 receptor. Secondary (acquired) GH insensitivity results from antibodies to growth hormone or the growth hormone receptor, as well as poor nutritional status, liver disease or diabetes mellitus. A GHR mutation that results in only partial insensitivity to GH can manifest as a form of idiopathic short stature.
The Don Cossack Host (Russian: Всевеликое Войско Донское, Vsevelikoye Voysko Donskoye) was either an independent or an autonomous democratic republic, located in present-day Southern Russia. It existed from the end of the 16th century until the early 20th century. There are two main theories of the origin of the Don Cossacks. Most respected historians support the migration theory, according to which they were Slavic colonists. The various autochthonous theories popular among the Cossacks themselves do not find confirmation in genetic studies. The gene pool comprises mainly the East Slavic component, with a significant Ukrainian contribution. There is no influence of the peoples of the Caucasus; and the steppe populations, represented by the Nogais, have only limited impact. The majority of Don Cossacks are either Eastern Orthodox or Christian Old Believers (старообрядцы). Prior to the Russian Civil War, there were numerous religious minorities, including Muslims, Subbotniks, and Jews.
Ádám István Mechler is a materials scientist and academic most known for his research on intermolecular interactions in physical chemistry, as well as on molecular machines, hierarchical metamaterials, and self-assembling systems inspired by biology. He is a professor of Chemistry at La Trobe University, Australia, where he leads the Bioinspired self-assembling nanostructures research group. He is also the Academic Program Director of the IIT Kanpur - La Trobe University Research Academy and the BITS Pilani - La Trobe University joint PhD program.
Sources: en.wikipedia.org
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.
The synthetic peptide incorporates modifications that slow enzymatic breakdown in circulation. Native growth hormone-releasing hormone is short-lived, whereas the analog is designed for greater stability. The core amino acid backbone is largely retained.
The main studied application is reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. Research has measured fat changes through imaging. Findings concern fat distribution rather than overall body weight.
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.